eP149: Safety and efficacy of pegunigalsidase alfa, every 4 weeks, in Fabry disease: Results from the phase 3, open-label, BRIGHT study
| Autor: | Bernat, John, Holida, Myrl, Longo, Nicola, Goker-Alpan, Ozlem, Wallace, Eric, Deegan, Patrick, Nedd, Khan, Tondel, Camilla, Eyskens, Francois, Feldt-Rasmussen, Ulla, Pisani, Antonio, Rocco, Rossana, Almon, Einat, Alon, Sari, Chertkoff, Raul, Warnock, David, Waldek, Stephen, Wilcox, William |
|---|---|
| Zdroj: | In Genetics in Medicine March 2022 24(3) Supplement:S91-S92 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|